ArticleBritish journal of pharmacology2011

Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline.

Lei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.